Evolution of Immunosuppressive Agents in Renal Transplantation: An Updated Review

Abstract

Suppression of allograft rejection is the central issue in renal transplantation (RT). Thus, development of immunosuppressive agents is the key for successful allograft function. Immunosuppression agents in RT have evolved over the last six decades beginning with total lymphoid irradiation to the currently available immunosuppressive strategies, which have significantly reduced the incidence of acute rejection episodes and improved short-term graft and patient outcomes. However their use is associated with long-term graft dysfunction, hypertension, hyperlipidaemia, diabetes mellitus, infections and malignancies. Chronic antibody-mediated rejection and chronic allograft dysfunction still remain the major problems, often leading to graft loss and shortened long-term graft survival. Immunosuppressive agents are used for induction, maintenance and reversal of established rejection. The use of multidrug regimen tailored to the immunological risk of patient and adverse-effect profile of the drug provides the optimum outcomes.This review focuses on the evolution of immunosuppression agents used in RT over last six decades and highlights the newer agents under investigation.

Authors and Affiliations

Badri Shrestha

Keywords

Related Articles

Multipotent Mesenchymal Stromal Cells Derived from the Bone Marrow Transported Over 12 Hours Change Their Main Characteristics

Multipotent Mesenchymal Stromal Cells Derived from the Bone Marrow Transported Over 12 Hours Change Their Main Characteristics

Generation and characterization of induced pluripotent stem cells in domestic Asian water buffalo (Bubalus bubalis)

Induced pluripotent stem cells (iPSCs) have numerous applications in livestock to improve production traits, disease resistance, biopharming, conservation of germplasm, disease modeling, regenerative medicine etc. Here,...

Circulating Endothelial Progenitor Cells in Women with Coronary Microvascular Dysfunction: A Pilot Study

Background: Endothelial progenitor cells (EPCs) are a diverse population of mononuclear cells derived from bone marrow that are mobilized in response to vascular injury, circulate in peripheral blood and contribute to va...

Bioscaffold Augmentation of the Alveolar Bone: A Pilot Study in the Rabbit to Define the Protocol

Purpose: The current study aims to establish, for the first time, a model to determine the surgical and tissue processing protocols for testing the use of a synthetic bone graft material to augment the contour and volume...

Is There Blinding Onchocerciasis in Northern Uganda?

Background: Onchocerciasis is a filarial nematode Onchocerca volvulus transmitted by female black flies which breeds in fast flowing rivers. Clinical manifestations is ocular or skin lesions. The long-term armed conflict...

Download PDF file
  • EP ID EP198001
  • DOI 10.19070/2328-3548-1600027
  • Views 78
  • Downloads 0

How To Cite

Badri Shrestha (2016). Evolution of Immunosuppressive Agents in Renal Transplantation: An Updated Review. International Journal of Stem Cell Research and Transplantation (IJST), 4(3), 158-172. https://europub.co.uk/articles/-A-198001